Gastroenterology

Explore the complexities of Gastroenterology research and treatment in China’s pharmaceutical industry. At Fineline Info & Tech, we provide reliable data, news, and insights to enhance your understanding and decision-making. Stay informed and stay ahead in the fight against Gastroenterology with flcube.com.

Edding Genor Secures Dual NMPA IND Approvals for GB268 – PD‑1/CTLA‑4/VEGF Trispecific Antibody Advances into NSCLC and First‑Line Biliary Tract Cancer Trial

Edding Genor (HKG: 6998) announced that China's National Medical Products Administration (NMPA) has approved two investigational new drug (IND) applications for GB268, the company's highly differentiated PD‑1/CTLA‑4/VEGF trispecific antibody: a…

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.